Medindia LOGIN REGISTER
Medindia
Advertisement

US Market Overview for Immunology Drugs 2018 - MedView

Tuesday, November 7, 2017 Drug News
Advertisement
NEW YORK, Nov. 6, 2017 /PRNewswire/ -- The report is an extensive market analysis study on the current biologics such as ORENCIA®, HUMIRA®, CIMZIA®, Enbrel®, SIMPONI®, REMICADE®, RITUXAN®, Actemra®, STELARA®, ENTYVIO® and TYSABRI ®. The others segment includes XELJANZ®, promising biologics in pipeline consisting of JAK inhibitors (imposing competition to XELJANZ®) and other TNF and interleukin biologics that will enter the market during the forecast period.Read the full report: https://www.reportlinker.com/p05175231Some of these biologics are approved and used in more than one conditions. Therefore, the market is segmented by diseases. The report comprises market analyses on rheumatoid arthritis, ankylosing spondylitis, Crohn`s disease, ulcerative colitis and psoriasis drugs globally.AbstractThe U.S. immunology market includes biologic drugs that are used in the treatment of various immunology diseases such as rheumatoid arthritis (RA), ankylosing spondylitis (AS), Crohn`s disease (CD), ulcerative colitis (UC) and psoriasis (PsO). As there is a need for cost effective drugs in treating these diseases, there is an increased number of drugs in development for these diseases. Current treatment mainly constitutes NSAIDs and biologics. However, this report is limited to biologics, as they constitute 90% of the revenue in immunology. The reports covers second line treatments, their dosage, comparative cost studies, market size and revenue forecasts.Scope2014-2024Read the full report: https://www.reportlinker.com/p05175231 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. https://www.reportlinker.com __________________________ Contact Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001

View original content:http://www.prnewswire.com/news-releases/us-market-overview-for-immunology-drugs-2018---medview-300550588.html

SOURCE Reportlinker

Sponsored Post and Backlink Submission


Latest Press Release on Drug News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close